Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The triptan formulations: a critical evaluation.

Marcelo E Bigal1, Carlos A Bordini, Ana L Antoniazzi

  • 1Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA. marcelobigal@aecom.yu.edu

Arquivos De Neuro-Psiquiatria
|June 14, 2003
PubMed
Summary

Triptans are essential migraine treatments, with various formulations available. While pharmacological differences exist, clinical distinctions are subtle, requiring personalized patient selection for optimal migraine relief.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic Unilateral Headache Related to Scar Neuromas.

Journal of medical cases·2023
Same author

Migraine and balance impairment: Influence of subdiagnosis, otoneurological function, falls, and psychosocial factors.

Headache·2022
Same author

Migraine With Aura Is Related to Delayed Motor Control Reaction and Imbalance Following External Perturbations.

Frontiers in neurology·2021
Same author

Is kinesiophobia related to fear of falling, dizziness disability, and migraine disability in patients with migraine?

Physiotherapy theory and practice·2021
Same author

Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study.

Headache·2021
Same author

The Influence of Photophobia on Postural Control in Patients With Migraine.

Headache·2020

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Migraine-specific triptans have transformed acute migraine attack management.
  • Various triptan formulations exist, including oral, nasal, injectable, and suppository options.

Purpose of the Study:

  • To explore the pharmacological differences among triptans.
  • To discuss how these differences may influence clinical efficacy and patient selection.
  • To highlight the importance of personalized treatment strategies for migraine.

Main Methods:

  • Review of pharmacological profiles of different triptans.
  • Analysis of pharmacokinetic parameters (T1/2, Tmax, Cmax, AUC) and metabolism.
  • Consideration of drug-drug interaction profiles and delivery system impacts.

Related Experiment Videos

Main Results:

  • Triptans exhibit distinct pharmacological profiles, but clinical efficacy differences are not well-defined.
  • Subtle clinical distinctions necessitate individualized triptan selection based on patient characteristics and preferences.
  • Delivery systems can significantly impact the onset of triptan action.

Conclusions:

  • Optimizing acute migraine treatment requires matching individual patient needs with specific triptan characteristics.
  • Clinicians must consider migraine attack severity, associated symptoms, comorbidities, and potential drug interactions.
  • Familiarity with various triptans and formulations allows for improved therapeutic benefit in migraine management.